The role of calpain in oncotic cell death

被引:183
作者
Liu, XL [1 ]
Van Vleet, T
Schnellmann, RG
机构
[1] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA
[2] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA
关键词
calcium; oncosis; plasma membrane permeability; cytoskeleton; mitochondria;
D O I
10.1146/annurev.pharmtox.44.101802.121804
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Numerous lines of evidence demonstrate that calpains, a family of 14 Ca2+-activated neutral cysteine proteases, are involved in oncotic cell death in a variety of models. At this time, the biochemistry of most calpains and the specific roles of different calpains in physiology and pathology remain to be determined. A number of calpain substrates have been identified in cellular systems, including cytoskeletal proteins, and recent studies suggest that calpains mediate the increase in plasma membrane permeability to ions and the progressive breakdown of the plasma membrane observed in oncosis through the proteolysis of cystokeletal and plasma membrane proteins. Further, a number of reports provide evidence that the mitochondrial dysfunction observed in oncosis may be mediated by a mitochondrial calpain of unknown identity. Finally, a number of diverse calpain inhibitors have been developed that show cytoprotective properties in cellular systems and in vivo following diverse insults. It is suggested that future research be directed toward elucidation of the role(s) of specific calpain isozymes in physiological and pathological conditions; identifying and linking specific calpain substrates with altered cellular functions; and developing cell-permeable, potent, isozyme-selective calpain inhibitors.
引用
收藏
页码:349 / 370
页数:22
相关论文
共 155 条
[21]   Neuronal recovery after moderate hypoxia is improved by the calpain inhibitor MDL28170 [J].
Chen, ZF ;
Schottler, F ;
Lee, KS .
BRAIN RESEARCH, 1997, 769 (01) :188-192
[22]  
CHOI DW, 1995, TRENDS NEUROSCI, V18, P58
[23]   A BIOCHEMICAL HALLMARK OF APOPTOSIS - INTERNUCLEOSOMAL DEGRADATION OF THE GENOME [J].
COMPTON, MM .
CANCER AND METASTASIS REVIEWS, 1992, 11 (02) :105-119
[24]   Immunoaffinity purification of the calpains [J].
Cong, JY ;
Thompson, VF ;
Goll, DE .
PROTEIN EXPRESSION AND PURIFICATION, 2002, 25 (02) :283-290
[25]   THE DESIGN OF PEPTIDYLDIAZOMETHANE INHIBITORS TO DISTINGUISH BETWEEN THE CYSTEINE PROTEINASES CALPAIN-II, CATHEPSIN-L AND CATHEPSIN-B [J].
CRAWFORD, C ;
MASON, RW ;
WIKSTROM, P ;
SHAW, E .
BIOCHEMICAL JOURNAL, 1988, 253 (03) :751-758
[26]  
CREENBAUM D, 2000, CHEM BIOL, V7, P569
[27]   CALCIUM-ACTIVATED NEUTRAL PROTEASE (CALPAIN) SYSTEM - STRUCTURE, FUNCTION, AND REGULATION [J].
CROALL, DE ;
DEMARTINO, GN .
PHYSIOLOGICAL REVIEWS, 1991, 71 (03) :813-847
[28]   DIFFERENTIAL PROTEOLYSIS OF THE FULL-LENGTH FORM OF THE L-TYPE CALCIUM-CHANNEL ALPHA-1 SUBUNIT BY CALPAIN [J].
DEJONGH, KS ;
COLVIN, AA ;
WANG, KKW ;
CATTERALL, WA .
JOURNAL OF NEUROCHEMISTRY, 1994, 63 (04) :1558-1564
[29]   Selective down-regulation of IP3 receptor subtypes by caspases and calpain during TNFα-induced apoptosis of human T-lymphoma cells [J].
Diaz, F ;
Bourguignon, LYW .
CELL CALCIUM, 2000, 27 (06) :315-328
[30]   Distribution of epithelial ankyrin (Ank3) spliceoforms in renal proximal and distal tubules [J].
Doctor, RB ;
Chen, J ;
Peters, LL ;
Lux, SE ;
Mandel, LJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (01) :F129-F138